LEADER 01210nam 2200409 450 001 9910796523103321 005 20230126215757.0 010 $a93-86602-23-7 035 $a(CKB)4100000001038393 035 $a(MiAaPQ)EBC4947499 035 $a(Au-PeEL)EBL4947499 035 $a(CaPaEBR)ebr11463856 035 $a(CaONFJC)MIL1027590 035 $a(OCoLC)1011249921 035 $a(EXLCZ)994100000001038393 100 $a20201110d2017 uy 0 101 0 $amar 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aGunatmak Sanshodhanachi Karyapaddhati. /$fSharlene Hesse Biber 210 1$aNew Delhi, India :$cSAGE Publications,$d2017. 215 $a1 online resource (375 pages) $cillustrations 311 $a93-86602-21-0 320 $aIncludes bibliographical references and index. 606 $aSocial sciences 615 0$aSocial sciences. 676 $a300.7 700 $aHesse-Biber$b Sharlene Nagy$01490113 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910796523103321 996 $aGunatmak Sanshodhanachi Karyapaddhati$93861124 997 $aUNINA LEADER 03220oam 2201033zu 450 001 9910698292303321 005 20251017110116.0 035 $a(CKB)3450000000002085 035 $a(SSID)ssj0000622364 035 $a(PQKBManifestationID)11400719 035 $a(PQKBTitleCode)TC0000622364 035 $a(PQKBWorkID)10641900 035 $a(PQKB)24198499 035 $a(WaSeSS)Ind00030457 035 $a(OCoLC)66400291 035 $a(DNLM)1275368 035 $a(EXLCZ)993450000000002085 100 $a20160829d2006 uy 101 0 $aeng 135 $aur||||||||||| 181 $ctxt 182 $cc 183 $acr 200 00$aManagement of adnexal mass 210 31$a[Place of publication not identified]$cAHRQ$d2006 215 $a1 online resource 225 1 $aEvidence Reports/Technology Assessments ;$vno. 130 225 1 $aAHRQ publication ;$vno. 06-E004 300 $aBibliographic Level Mode of Issuance: Monograph 320 $aIncludes bibliographical references. 410 0$aEvidence report/technology assessment ;$vno. 130. 410 0$aAHRQ publication ;$vno. 06-E004. 606 $aEndocrine Gland Neoplasms 606 $aOvarian Diseases 606 $aCysts 606 $aEvidence-Based Practice 606 $aClinical Medicine 606 $aGenital Neoplasms, Female 606 $aMedicine 606 $aAdnexal Diseases 606 $aNeoplasms 606 $aGonadal Disorders 606 $aEndocrine System Diseases 606 $aHealth Occupations 606 $aNeoplasms by Site 606 $aUrogenital Neoplasms 606 $aFemale Urogenital Diseases 606 $aDisease 606 $aGenital Diseases, Female 606 $aFemale Urogenital Diseases and Pregnancy Complications 606 $aEvidence-Based Medicine 606 $aOvarian Neoplasms 606 $aOvarian Cysts 606 $aMedicine$2HILCC 606 $aHealth & Biological Sciences$2HILCC 606 $aGynecology & Obstetrics$2HILCC 615 2$aEndocrine Gland Neoplasms. 615 2$aOvarian Diseases. 615 2$aCysts. 615 2$aEvidence-Based Practice. 615 2$aClinical Medicine. 615 2$aGenital Neoplasms, Female. 615 2$aMedicine. 615 2$aAdnexal Diseases. 615 2$aNeoplasms. 615 2$aGonadal Disorders. 615 2$aEndocrine System Diseases. 615 2$aHealth Occupations. 615 2$aNeoplasms by Site. 615 2$aUrogenital Neoplasms. 615 2$aFemale Urogenital Diseases. 615 2$aDisease. 615 2$aGenital Diseases, Female. 615 2$aFemale Urogenital Diseases and Pregnancy Complications. 615 2$aEvidence-Based Medicine. 615 2$aOvarian Neoplasms. 615 2$aOvarian Cysts. 615 7$aMedicine 615 7$aHealth & Biological Sciences 615 7$aGynecology & Obstetrics 676 $a618.1/1 702 $aMyers$b Evan R. 712 02$aUnited States Agency for Healthcare Research and Quality 712 02$aDuke University Evidence-based Practice Center, 801 0$bPQKB 906 $aBOOK 912 $a9910698292303321 996 $aManagement of adnexal mass$93136283 997 $aUNINA